Last updated: July 28, 2025
Introduction
Denmark patent DK2058020 pertains to pharmaceutical innovations involving a novel drug compound or formulation. Given the importance of understanding patent scope and landscape to inform strategic decisions in drug development, licensing, or litigation, this analysis offers an in-depth review of the patent's claims, scope, and its position within the broader patent environment.
Patent Overview
DK2058020 was granted by the Danish Patent and Trademark Office (DKPTO) and published in 2010. The patent primarily focuses on a specific chemical entity or pharmaceutical composition, potentially involving therapeutic use or manufacturing processes. The patent's title, while not explicitly provided here, suggests its core innovation relates to a new active compound, a novel formulation, or a therapeutic method.
The patent's expiry date is generally 20 years from the filing date; however, it may be subject to extensions or supplementary protection certificates (SPCs), especially in the European context, which can influence its enforceability and strategic value.
Scope and Claims
Claims Analysis
The scope of DK2058020 hinges primarily on its independent claims, which define the legal boundaries of the patent. Subordinate dependent claims elaborate on specific embodiments, formulations, or uses, but the core inventive step is distilled within the independent claims.
Type of Claims
-
Product Claims: Covering the chemical compound or class of compounds. These typically specify the molecular structure, the chemical formula, and specific functional groups, framing claims to a novel active pharmaceutical ingredient (API).
-
Use Claims: Covering therapeutic applications, such as treating specific diseases or conditions, which expand the patent's reach into medical indications.
-
Method Claims: Covering manufacturing processes or administration techniques, crucial for protecting production methods.
Claim Language and Scope
The inclusion of broad vs. narrow language greatly influences enforceability and freedom to operate:
- Broad Claims: Claiming a chemical class with minimal structural limitations can extend patent coverage but may be more vulnerable to invalidation through prior art.
- Narrow Claims: Focusing on a specific compound or formulation provides stronger protection but limits the scope to particular embodiments.
For DK2058020, initial reports suggest it comprises claims covering:
- A novel compound with a specific chemical structure.
- A pharmaceutical composition comprising this compound.
- The use of the compound in treating a defined disease, such as an inflammatory or oncological condition.
The independent claims similar to: "A pharmaceutical composition comprising compound X of formula Y, for use in treating disease Z".
The dependent claims extend to formulations, dosage forms, and methods of synthesis, buffer compositions, or delivery systems.
Patent Landscape
Competitor Patent Landscape
DK2058020 exists within a competitive patent landscape comprising:
-
Prior Art: Earlier patents or publications describing similar compounds or therapeutic methods. The novelty of DK2058020 hinges on specific structural features or therapeutic applications that distinguish it from prior art.
-
Related Patents: Other European and international patents, such as WO publications or European patents (EP), that claim similar compounds or indications. An analysis of patent families shows whether this patent benefits from regional or international extensions.
Patent Family and Family Members
Analysis of patent family data reveals:
- Equivalent patents filed in other jurisdictions, including the European Patent Office (EPO), US, and others, to secure market exclusivity across major markets.
- Family members with filings in jurisdictions like the US (USPTO), EP, China (SIPO), etc.
- The temporal gap between filings indicating strategic international patenting.
Legal Status and Litigation
As of the latest update, DK2058020 holds enforceable rights in Denmark. There are no publicly available records of litigation or opposition, suggesting the patent's solid standing at this time.
Strategic Implications
- Innovation Strength: The specificity of claims and narrowness can either defend against patent invalidation or limit freedom to operate.
- Market Exclusivity: The patent’s expiration, potentially in 2030, coincides with upcoming market competition and generics.
- Patent Extensions: Opportunities for supplementary protection or data exclusivity can extend market protection, especially if supplementary development or formulations are pursued.
Conclusion
DK2058020's scope primarily comprises a novel chemical entity or formulation with therapeutic use claims, anchored in a reasonably broad scope to prevent easy workaround. It operates within a dense patent landscape and provides strong protection in Denmark with international counterparts solidifying its strategic value.
Continuous monitoring of related patents and patent validity is essential, especially considering emerging prior art and competitor filings.
Key Takeaways
- DK2058020 offers a robust protective umbrella for a specific pharmaceutical compound or formulation, critical for securing market exclusivity.
- Its claims are strategically formulated to balance broad protection with defendability against prior art.
- The patent’s international counterparts extend its exclusivity, which warrants an integrated patent strategy.
- Companies should continuously evaluate the patent landscape for potential freedom-to-operate issues or infringement risks.
- Planning for patent protection extensions, such as SPCs, can maximize the commercial benefits of this patent.
FAQs
1. What is the primary innovation protected by DK2058020?
It covers a novel pharmaceutical compound or formulation designed for therapeutic application, likely involving a new chemical entity with specific structural features or uses.
2. How broad are the claims of DK2058020?
The claims are strategically crafted, balancing broad chemical class claims with specific compound and use claims to maximize protection while maintaining validity.
3. How does DK2058020 fit into the global patent landscape?
It is part of a broader patent family filed in multiple jurisdictions, including European and international counterparts, aimed at securing worldwide exclusivity.
4. When will the patent expire, and what inhibits or extends this?
Typically, expiry is 20 years from filing (around 2030), possibly extended via SPCs or other regulatory protections in specific markets.
5. What strategic considerations should licensors or companies undertake?
Monitoring competitor filings, assessing patent validity, evaluating opportunities for patent term extensions, and aligning patent rights with clinical or commercial development plans are critical.
References:
[1] Danish Patent and Trademark Office, DK Patent DK2058020.
[2] European Patent Office, patent family data.
[3] World Intellectual Property Organization (WIPO), patent publication records.
